European Pharmaceutical Review

SEPTEMBER 7, 2023

The UK’s association is set to create and support thousands of new job opportunities, helping to deliver the ambition to grow the economy and cement the UK as a science and technology superpower by 2030.

Government 79

Government Competition Pharmaceutical Manufacturing 79

pharmaphorum

JANUARY 19, 2023

Deuroxilitinib (formerly CTP-543) – a JAK 1/2 inhibitor – is coming up against drugs in the class from Eli Lilly and Pfizer in the alopecia areata market, so will face heavyweight competition, although Sun reckons it is a “best in class” therapy. The report predicts that the alopecia areata market will grow to as much as $2.5

Pharma 80

Pharma Marketing FDA Competition 80

Contrarian Sales Techniques

JANUARY 30, 2023

According to the Bureau of Labor Statistics, employment of medical and pharmaceutical sales representatives is projected to grow 3 percent from 2020 to 2030, about as fast as the average for all occupations. However, the industry is becoming more competitive and navigating the industry is becoming harder.

Medical sales 52

Medical sales Sales Medical Healthcare Provider 52

pharmaphorum

JANUARY 16, 2023

The bi-weekly intramuscular shot – which was also approved in China in 2021 – will enter a crowded market for long-acing injectable (LAI) schizophrenia therapies in the US and have to take on heavyweight competition, including drugs that require less frequent dosing.

FDA 52

FDA Pharma Marketing Competition 52

pharmaphorum

OCTOBER 10, 2022

The pharma group said earlier this year it is hoping for eight new cardiovascular therapy approvals between now and 2030, for diseases like atherosclerosis, heart failure, and thrombosis as well as PAH, that will swell its sales from in the category to $10 billion around the end of the decade.

Sales 52

Sales FDA Pharma Competition 52

pharmaphorum

NOVEMBER 8, 2022

” Lilly is trying to stay ahead of rivals Novo Nordisk and Sanofi in an increasingly competitive insulin market, as well as tapping into the trend to make medicines safer and more effective through the use of digital technologies. billion in 2020 to more than $16 billion by 2030, according to GlobalData.

Management 62

Management Physicians Marketing Education 62

pharmaphorum

JANUARY 24, 2023

In this final instalment of IQVIA EMEA Thought Leadership’s Nine for 2023 three-part series, focusing on issues that will change the direction of healthcare and the pharmaceutical industry this year, three key competitive issues for pharmaceutical companies in 2023 are assessed.

Medicine 88

Medicine Healthcare Healthcare Pharma 88

Pharmaceutical Technology

JULY 21, 2022

Pharma giant AstraZeneca also plans to make its supply chain carbon-negative by 2030; to reduce its Scope 1 emissions by 20%, Scope 2 emissions by 95%, and Scope 3 emissions by 25% per $1m of sales by 2025. In 2020, Fisher & Paykel Healthcare, a medical devices firm, made a SBTi commitment to reduce GHG emissions by 67% by 2034.

Government 52

Government Healthcare Healthcare Pharma 52

Medico Reach

FEBRUARY 8, 2023

from 2022 to 2030, the pharma industry will reach USD 9,241.34 million by 2030. from 2023 to 2030. Now is the time for various B2B businesses targeting the pharma industry to buckle up, get competitive and align their strategies for propensity. Poised to grow at a CAGR of 29.4%

Pharma 52

Pharma Medicine Marketing Prospecting 52

Sales Talent

JANUARY 20, 2022

However, before you jump directly to our sales hiring predictions for 2022, take the time to read the entire article to learn how the intense competition for talent is impacting sales professionals’ salaries and employers’ strategies for winning the talent war. jobs by 2030 while the workforce will only grow by 8.9M.

Sales 52

Sales B2B Sales Competition Insurance 52

Clarivate

MAY 31, 2023

Pharma M&A activity was muted in 2022, coming in at its lowest level since 2013 – something of a surprise, given the looming patent cliff and pharma’s past reliance on M&A and biopartnering as a quick fix for revenues lost to generics and biosimilars competition. billion based on seven preclinical ADC candidates.

Pharma 52

Pharma Biopharma Medicine Competition 52

Pharmaceutical Technology

NOVEMBER 23, 2022

Lifted by increased interest after the onset of the Covid-19 pandemic, the sector is expected to balloon to US$853 billion by 2030. Hamilton offers more competitive prices than Toronto and the city is only an hour away from its larger neighbour. City Competitiveness Index. per square foot (/ft2) in Hamilton, versus C$9.06/ft2

Marketing 52

Marketing Manufacturing Transportation Government 52

Spotio

MARCH 25, 2024

In fact, experts claim that 15% of American households will have solar photovoltaic (PV) systems in place by 2030. This indicates enormous potential for solar companies—but competition for business is fierce. Your company will be compared to the competition to see how it stacks up. If it can’t, it won’t.

Sales 52

Sales Prospecting Sales process Sales pitches 52

Every Ancillary

MAY 14, 2021

According to one estimate from P&S Research , this market is expected to grow nearly 5x by 2030! Cons: Highly competitive with new options continually emerging. The Regenerative Medicine sector has exploded in popularity in recent years, with that trend expected to continue for the foreseeable future.

Medical sales 52

Medical sales Medical Sales Insurance 52

European Pharmaceutical Review

MARCH 24, 2023

According to GlobalData, competition to develop a first-to-market drug for NASH is strong. In the European Union, NASH affects nearly 10 million people and is expected to increase by more than 40 percent by 2030. 89bio is one of several companies advancing treatments. It is becoming the leading cause for liver transplants.

Medical 85

Medical Side effects Safety Pharmaceutical 85

pharmaphorum

NOVEMBER 10, 2022

Expressing a desire that a shared passion for innovation and excellence within cancer care should be put at the centre of policies in order to establish resilience and competitiveness, Montserrat did note that sustainability was also important across the 27 EU member states. Horizon Europe and cancer care post-2020.

Electronics 78

Electronics Government Patients Pharma 78

Medico Reach

OCTOBER 17, 2022

from 2022 to 2030. The potential increase in industry competition could also spell trouble for some. Grand View Research published a report recently that captured some interesting highlights about the orthopedic medical device industry. The article puts the global market size for the sector at $40.9

Medical 98

Medical Food and Drug Administration Healthcare Healthcare 98

Spotio

FEBRUARY 9, 2023

Furthermore, the organization predicts it will outpace the GDP by 2030. Increased competition Your sales team also faces more competition than ever before. This method won’t cut it in years to come if you expect to separate yourself from the competition. The medical field is growing. What does this look like?

Sales 52

Sales Medical Doctors Sales process 52

pharmaphorum

JANUARY 4, 2023

The Proposal hopes to address the concerns with the current system and support the EC’s vision for the EU’s digital transformation by 2030. It has been proposed that the amount of these fees charged by the data holder must be transparent, proportionate, and “must not restrict competition” 10. Rights for individuals.

Pharmaceutical 86

Pharmaceutical Electronics Healthcare Healthcare 86

European Pharmaceutical Review

DECEMBER 21, 2022

16,17 However, care must be taken to ensure that chemicals from biomass are not produced in competition with food production and do not have a negative impact on the environment or natural habitats. In the context of CO 2 neutrality, the years 2030 and 2050 are mentioned as crucial milestones.

Manufacturing 77

Manufacturing Pharmaceutical Healthcare Healthcare 77

Medico Reach

OCTOBER 17, 2022

from 2022 to 2030. The potential increase in industry competition could also spell trouble for some. Grand View Research published a report recently that captured some interesting highlights about the orthopedic medical device industry. The article puts the global market size for the sector at $40.9

Medical 52

Medical Food and Drug Administration Healthcare Healthcare 52

PM360

AUGUST 9, 2022

ZS analysis shows the top pharma companies have more than $230B in worldwide revenues at risk from 2022 to 2030; the top 10 pharma companies combined have more than 45% of their revenues at risk. Ask: Is this component truly a competitive advantage? During this time, 69 blockbusters will lose patents. The Payoff Is Real.

Biopharma 69

Biopharma Marketing Healthcare Healthcare 69

Healthcare Success

NOVEMBER 14, 2022

billion in 2030 ). Differentiating medical devices can be challenging due to commoditization and the fast pace of technological advances, but it’s critical to stand out in a competitive device market. Over the next seven years, the medical device market will nearly double in size (from USD 495.46 billion in 2022 to 964.90

Medical 69

Medical Marketing Engineering Doctors 69

Pharmaceutical Technology

MAY 22, 2023

billion) by 2030. As the COVID-19 pandemic continues to take its toll on businesses worldwide, it’s time to look for new ways to create value, prepare for the future, and remain competitive in the ever-changing landscape. The UK government also has its own plans for funding research. billion ($18.2 Horizon Europe has a budget of €95.5

Marketing 111

Marketing Government Prospecting Medicine 111

Pharmaceutical Technology

MAY 26, 2023

Touchlight estimates that the DNA market is currently worth $1bn and will grow 20% annually until 2030. As the COVID-19 pandemic continues to take its toll on businesses worldwide, it’s time to look for new ways to create value, prepare for the future, and remain competitive in the ever-changing landscape.

Manufacturing 52

Manufacturing Pharma Prospecting Marketing 52

Pharmaceutical Technology

JANUARY 11, 2023

By 2030, global spending on digital health is projected to represent 8% of all healthcare expenditure, up from 3% currently 2. Funding has followed the technology, with the digital health sector seeing significant growth globally due to strong investor confidence and perceived investment opportunities.

Healthcare 52

Healthcare Healthcare Medical Electronics 52

Pharmaceutical Technology

DECEMBER 15, 2022

The BioPIPS project is in line with Singapore’s wider “Manufacturing 2030” program, which aims to boost the country’s manufacturing by 50%. According to GlobalData’s Contract Service Provider database, Merck & Co currently owns three facilities in Singapore, and Novartis and GSK each own two facilities.

Manufacturing 105

Manufacturing Pharma Engineering Government 105

Pharmaceutical Technology

JUNE 15, 2023

Led by a multidisciplinary committee of patient advocacy leaders, healthcare professionals, biosimilar experts, and industry leaders from across the globe, it aims to increase biosimilar adoption by 30 percentage points in over 30 countries by 2030. 2021 was a year of continued innovation and change in the Biopharmaceutical industry.

Education 52

Education Patients Healthcare Healthcare 52

Pharmaceutical Technology

JUNE 19, 2023

According to a GlobalData epidemiology forecast, there will be nearly 190 million cases of dysphagia globally by 2030. As the COVID-19 pandemic continues to take its toll on businesses worldwide, it’s time to look for new ways to create value, prepare for the future, and remain competitive in the ever-changing landscape.

Medicine 52

Medicine Manufacturing Marketing Pharmaceutical 52

Pharmaceutical Technology

FEBRUARY 24, 2023

The WHO’s 2020 global strategy sets out its vision of cervical cancer being eliminated as a public health problem by 2030 and outlines a pathway with strategic actions to achieve its goal. 2021 was a year of continued innovation and change in the Biopharmaceutical industry.

Prospecting 116

Prospecting Competition Medicine Leads 116

Clarivate

DECEMBER 14, 2023

IDNs coalesce along Competitive Service Regions As nonprofit IDNs push out from their home markets and for-profit and Catholic IDNs pull back from earlier expansions, distinct competitive service regions with common rivalries are developing across the nation. Typically, BCBS plans offer an iteration of VBC to providers in their state.

Marketing 52

Marketing Healthcare Healthcare Insurance 52